Literature DB >> 6967918

Inhibition of concanavalin A-induced human lymphocyte mitogenic factor (Interleukin-2) production by suppressor T lymphocytes.

H Northoff, C Carter, J J Oppenheim.   

Abstract

Supernatants of fresh human MNL stimulated with concanavalin A (Con A) generally contain little or no lymphocyte-derived mitogenic factor (LMF or Interleukin-2). However, preincubation of MNL in culture medium for 2 to 5 days before stimulation with Con A rendered them capable of producing increasing LMF. The production of LMF by reincubated MNL was inhibited by readdition of autologous fresh MNL or E-rosetting (T) lymphocytes. The producing cells were T lymphocytes; however, the production of LMF was monocyte dependent. LMF eluted from a Sephadex G150 column in 2 peaks at 12 to 27,000 and 50 to 70,000 daltons. Both species of LMF were mitogenic for mouse (C3H/HeJ) thymocytes and for human T and B cells. LMF production was not affected by x-irradiation (less than or equal to 2500 R) before preincubation; it was, however, abolished by the addition of 10(-7) M hydrocortisone during the preincubation period. LMF production by fresh MNL could be moderately enhanced by the addition of cimetidine, a drug that is known to interfere with histamine H2 receptors on suppressor T cells. Presumably, preincubation of MNL reduces the activity of Con A-induced suppressor cells. We conclude that human peripheral blood contains suppressor T cells that when activated by Con A regulate the production of LMF by other T cells in response to Con A.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6967918

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

1.  Maintenance of antigen specificity by human interleukin-2-dependent T cell lines. Use of antigen-presenting cells and OKT3 antibody in the absence of antigen.

Authors:  S J Padula; M K Pollard; E G Lingenheld; R B Clark
Journal:  J Clin Invest       Date:  1985-03       Impact factor: 14.808

2.  The heterogeneity and functional capacities of human thymocyte subpopulations.

Authors:  C Gelin; L Boumsell; J Dausset; A Bernard
Journal:  Proc Natl Acad Sci U S A       Date:  1984-08       Impact factor: 11.205

3.  Inhibition of endotoxin-induced activation of human monocytes by human lipoproteins.

Authors:  W A Flegel; A Wölpl; D N Männel; H Northoff
Journal:  Infect Immun       Date:  1989-07       Impact factor: 3.441

4.  Prevention of endotoxin-induced monokine release by human low- and high-density lipoproteins and by apolipoprotein A-I.

Authors:  W A Flegel; M W Baumstark; C Weinstock; A Berg; H Northoff
Journal:  Infect Immun       Date:  1993-12       Impact factor: 3.441

5.  In vitro generation of splenic suppressor cells by trypsin.

Authors:  F Ulrich
Journal:  Immunology       Date:  1982-06       Impact factor: 7.397

6.  Correction of interleukin-2 production in patients with systemic lupus erythematosus by removal of spontaneously activated suppressor cells.

Authors:  M Linker-Israeli; A C Bakke; F P Quismorio; D A Horwitz
Journal:  J Clin Invest       Date:  1985-02       Impact factor: 14.808

7.  Deficient interleukin 2 activity in MRL/Mp and C57BL/6J mice bearing the lpr gene.

Authors:  D Wofsy; E D Murphy; J B Roths; M J Dauphinée; S B Kipper; N Talal
Journal:  J Exp Med       Date:  1981-11-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.